Chromosomal 20q gain in the DNA diploid component of aneuploid colorectal carcinomas

International Journal of Cancer

Volumn 120, Issue 12, 2007, Pages 2734-2738

  De Angelis, Paula M ^a,b   Stokke, Trond ^b   Beigi, Marzieh ^a   Flatberg, Gøril ^a   Enger, Marianne ^a   Haug, Kristiane ^a   Aass, Hans Christian D ^a   Schjølberg, Aasa ^a   Andresen, Per Arne ^b   Ariansen, Sarah ^b   Bø, Anne Signe ^b   Mjåland, Odd ^c   Clausen, Ole Petter ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c SØRLANDET HOSPITAL   (Norway)

Author keywords

20q13 gain; CGH; Chromosomal aberrations; DNA aneuploidy; DNA diploidy; FISH; Flow sorted colorectal tumors

Indexed keywords

DNA; DOUBLE STRANDED DNA; PROTEIN P53;

ANEUPLOIDY; ARTICLE; AURKA GENE; CHROMOSOME 18Q; CHROMOSOME 20Q; CHROMOSOME 4Q; CHROMOSOME 8P; CHROMOSOME IDENTIFICATION; COLORECTAL CARCINOMA; COMPARATIVE GENOMIC HYBRIDIZATION; DIPLOIDY; DNA CONTENT; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; ONCOGENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ZNF217 GENE;

ANEUPLOIDY; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 20; COLORECTAL NEOPLASMS; DIPLOIDY; DNA MUTATIONAL ANALYSIS; EPITHELIAL CELLS; FLOW CYTOMETRY; GENES, RAS; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LOSS OF HETEROZYGOSITY; MUTATION; NUCLEIC ACID HYBRIDIZATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34247488762     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22537     Document Type: Article

References (19)

1. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
2. Rajagopalan H, Lengauer C. Aneuploidy and cancer. Nature 2004; 432:338-41.
3. Giaretti W. A model of DNA aneuploidization and evolution in colorectal cancer. Lab Invest 1994;71:904-10.
4. Cahill DP, Lengauer C, Yu J, Riggins GJ, Willson JK, Markowitz SD, Kinzler KW, Vogelstein B. Mutations of mitotic checkpoint genes in human cancers. Nature 1998;392:300-3.
5. Wang Z, Cummins JM, Shen D, Cahill DP, Jallepalli PV, Wang TL, Parsons DW, Traverso G, Awad M, Silliman N, Ptak J, Szabo S, et al. Three classes of genes mutated in colorectal cancers with chromosomal instability. Cancer Res 2004;64:2998-3001.
6. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-31.
7. Ried T, Knutzen R, Steinbeck R, Blegen H, Schrock E, Heselmeyer K, du Manoir S, Auer G. Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 1996;15:234-45.
8. De Angelis PM, Clausen OPF, Schjølberg A, Stokke T. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes. Br J Cancer 1999;80:526-35.
9. Meijer GA, Hermsen MA, Baak JP, van Diest PJ, Meuwissen SG, Belien JA, Hoovers JM, Joenje H, Snijders PJ, Walboomers JM. Progression from colorectal adenoma to carcinoma is associated with non-random chromosomal gains as detected by comparative genomic hybridisation. J Clin Pathol 1998;51:901-9.
10. Geido E, Sciutto A, Rubagotti A, Oliani C, Monaco R, Risio M, Giaretti W. Combined DNA flow cytometry and sorting with k-ras2 mutation spectrum analysis and the prognosis of human sporadic colorectal cancer. Cytometry 2002;50:216-24.
11. Vindelov LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry 1983;3:323-7.
12. Andersen SN, Lovig T, Breivik J, Lund E, Gaudernack G, Meling GI, Rognum TO. K-ras mutations and prognosis in large-bowel carcinomas. Scand J Gastroenterol 1997;32:62-9.
13. Canzian F, Salovaara R, Hemminki A, Kristo P, Chadwick RB, Aaltonen LA, de la Chapelle A. Semiautomated assessment of loss of heterozygosity and replication error in tumors. Cancer Res 1996;56: 3331-7.
14. De Angelis PM, Stokke T, Smedshammer L, Lothe RA, Meling GI, Rofstad M, Chen Y, Clausen OPF. p53 expression is associated with a high degree of tumor DNA aneuploidy and incidence of p53 gene mutation, and is localized to the aneuploid component in colorectal carcinomas. Int J Oncol 1993;3:305-12.
15. Rennstam K, Baldetorp B, Kytola S, Tanner M, Isola J. Chromosomal rearrangements and oncogene amplification precede aneuploidization in the genetic evolution of breast cancer. Cancer Res 2001;61: 1214-9.
16. Savelieva E, Belair CD, Newton MA, DeVries S, Gray JW, Waldman F, Reznikoff CA. 20q gain associates with immortalization: 20q13.2 amplification correlates with genome instability in human papillomavirus 16 E7 transformed human uroepithelial cells. Oncogene 1997; 14:551-60.
17. Bischoff JR, Anderson L, Zhu Y, Mossie K, Ng L, Souza B, Schryver B, Flanagan P, Clairvoyant F, Ginther C, Chan CS, Novotny M, et al. A homologue of Drosophila aurora kinase is oncogenic and amplified in human colorectal cancers. EMBO J 1998; 17:3052-65.
18. Zhou H, Kuang J, Zhong L, Kuo WL, Gray JW, Sahin A, Brinkley BR, Sen S. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat Genet 1998; 20:189-93.
19. Nonet GH, Stampfer MR, Chin K, Gray JW, Collins CC, Yaswen P. The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells. Cancer Res 2001;61: 1250-4.